14 results
6-K
EX-99.1
AMYT
Amryt Pharma Plc
25 Feb 22
Current report (foreign)
4:05pm
as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects … shall be true and correct in all material respects (without duplication of materiality qualifiers) on and as of the date of any such Credit Extension
424B3
AMYT
Amryt Pharma Plc
1 Jul 21
Prospectus supplement
5:20pm
to be performed by it at or prior to the effective time;
subject to certain exceptions and materiality standards provided in the merger agreement … time;
subject to certain exceptions and materiality standards provided in the merger agreement, the representations and warranties of Amryt being true
F-4/A
AMYT
Amryt Pharma Plc
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
to certain exceptions and materiality standards provided in the merger agreement, the representations and warranties of Chiasma being true and correct … obligations under the merger agreement required to be performed by it at or prior to the effective time;
subject to certain exceptions and materiality
F-4
svuq9
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
jb2pn5z
2 Jun 21
Prospectus supplement
10:10am
424B3
l4p 9gtwlu41k
2 Jun 21
Prospectus supplement
10:09am
6-K
EX-99.1
r0h3823jtin
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
i9i1ml qgo04
5 May 21
Agreement and Plan of Merger
5:19pm
F-1
EX-2.1
mvr01e humn
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
ll0mtfg2fzw
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-3.1
x1wk46 3e
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
EX-10.5
44begi w2
11 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next